Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
Recruiting · NCT04339777 · Registry updated 2026-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity | Hemic and Lymphatic Diseases, Infections, Opportunistic Infections, T cell immunodeficiency primary, autoimmune disease, common variable immunodeficiency, immune system disorder, immunoproliferative disorder, inborn error of immunity, lymphatic system disorder, lymphoproliferative syndrome | Recruiting | Phase 2 | 2026-09-28 | NCT04339777 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | United States | 800 |